Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of “Hold” by Brokerages

Shares of Teladoc Health, Inc. (NYSE:TDOC) have earned an average rating of “Hold” from the sixteen research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and five have assigned a buy rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $7.5357.

TDOC has been the topic of several recent research reports. Bank of America lifted their target price on shares of Teladoc Health from $9.00 to $10.50 and gave the stock a “buy” rating in a research note on Tuesday, July 7th. Weiss Ratings restated a “sell (d-)” rating on shares of Teladoc Health in a research report on Wednesday, August 19th. Citigroup cut their price objective on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating for the company in a report on Monday, August 3rd. Finally, Canaccord Genuity Group decreased their target price on shares of Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th.

Teladoc Health Trading Down 2.3%

TDOC stock opened at $6.35 on Tuesday. Teladoc Health has a 12-month low of $4.40 and a 12-month high of $9.89. The business’s 50-day moving average is $7.91 and its 200 day moving average is $6.66. The stock has a market cap of $1.15 billion, a price-to-earnings ratio of -6.41 and a beta of 2.12.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, July 29th. The health services provider reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.04. The business had revenue of $606.93 million during the quarter, compared to analysts’ expectations of $615.44 million. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The business’s revenue was down 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.19) earnings per share. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. As a group, equities analysts forecast that Teladoc Health will post -0.89 EPS for the current fiscal year.

Institutional Trading of Teladoc Health

Several large investors have recently added to or reduced their stakes in TDOC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Teladoc Health by 2.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 193,714 shares of the health services provider’s stock worth $1,542,000 after acquiring an additional 5,235 shares during the period. NewEdge Advisors LLC raised its stake in Teladoc Health by 1,278.7% during the first quarter. NewEdge Advisors LLC now owns 11,305 shares of the health services provider’s stock worth $90,000 after purchasing an additional 10,485 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Teladoc Health by 5.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 447,992 shares of the health services provider’s stock worth $3,566,000 after purchasing an additional 24,124 shares during the period. Acadian Asset Management LLC acquired a new position in Teladoc Health in the 1st quarter valued at about $615,000. Finally, Envestnet Asset Management Inc. acquired a new position in Teladoc Health in the 2nd quarter valued at about $89,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.